These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37829934)

  • 1. Non-alcoholic Fatty Liver Disease and Gallstones: A Systematic Review.
    Slouha E; Biput SJ; Kuteyi A; Kalloo AE; Gorantla VR
    Cureus; 2023 Sep; 15(9):e45027. PubMed ID: 37829934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.
    Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
    World J Gastroenterol; 2015 May; 21(20):6287-95. PubMed ID: 26034364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
    García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
    Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population.
    Kichloo A; Solanki S; Haq KF; Dahiya D; Bailey B; Solanki D; Singh J; Albosta M; Wani F; Aljadah M; Shah H; Khan H; Jafri SM
    World J Gastrointest Pathophysiol; 2021 Mar; 12(2):14-24. PubMed ID: 33815863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
    Vernon G; Baranova A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population.
    Ruhl CE; Everhart JE
    Am J Gastroenterol; 2013 Jun; 108(6):952-8. PubMed ID: 23545713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease].
    Cherkashchenko NA; Livzan MA; Krolevets TS
    Ter Arkh; 2020 Apr; 92(2):48-54. PubMed ID: 32598718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of non-alcoholic fatty liver disease and hypercholesterolemia in patients with gallstone disease undergoing laparoscopic cholecystectomy.
    Singh K; Dahiya D; Kaman L; Das A
    Pol Przegl Chir; 2019 Nov; 92(1):18-22. PubMed ID: 32312927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study.
    Lu Y; Hu L; Song J; Wan J; Chen H; Yin J
    BMC Endocr Disord; 2021 Nov; 21(1):231. PubMed ID: 34794397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
    Quek J; Chan KE; Wong ZY; Tan C; Tan B; Lim WH; Tan DJH; Tang ASP; Tay P; Xiao J; Yong JN; Zeng RW; Chew NWS; Nah B; Kulkarni A; Siddiqui MS; Dan YY; Wong VW; Sanyal AJ; Noureddin M; Muthiah M; Ng CH
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):20-30. PubMed ID: 36400097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
    Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
    Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship.
    Arrese M; Cortés V; Barrera F; Nervi F
    Curr Opin Gastroenterol; 2018 Mar; 34(2):90-96. PubMed ID: 29266009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy.
    Ahmed F; Baloch Q; Memon ZA; Ali I
    Ann Med Surg (Lond); 2017 May; 17():7-13. PubMed ID: 28377802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?
    Ahmed MH; Ali A
    Scand J Gastroenterol; 2014 May; 49(5):521-7. PubMed ID: 24646400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
    Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
    Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
    McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
    JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study.
    Chang Y; Noh YH; Suh BS; Kim Y; Sung E; Jung HS; Kim CW; Kwon MJ; Yun KE; Noh JW; Shin H; Cho YK; Ryu S
    J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30469392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.
    Ore A; Akinloye OA
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.